 Atrial Natriuretic Factor
"Atrial Natriuretic Factor" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A potent natriuretic and vasodilatory peptide or mixture of different-sized low molecular weight PEPTIDES derived from a common precursor and secreted mainly by the HEART ATRIUM. All these peptides share a sequence of about 20 AMINO ACIDS.
| Descriptor ID |
D009320
|
| MeSH Number(s) |
D06.472.699.584.500 D12.644.548.585.500
|
| Concept/Terms |
Atrial Natriuretic Factor- Atrial Natriuretic Factor
- Auriculin
- ANP
- Natriuretic Peptides, Atrial
- ANF
- Atriopeptins
- Atrial Natriuretic Peptides
- Peptides, Atrial Natriuretic
alpha-Atrial Natriuretic Peptide- alpha-Atrial Natriuretic Peptide
- alpha Atrial Natriuretic Peptide
- ANP-(99-126)
- Atriopeptin (99-126)
- Cardionatrin I
- Atrial Natriuretic Factor (99-126)
- ANF (1-28)
- Atriopeptin (1-28)
- Atrial Natriuretic Factor (1-28)
- gamma ANP (99-126)
- alpha ANP
- Cardiodilatin (99-126)
- ANP Prohormone (99-126)
- ANF (99-126)
- ANP (1-28)
Atrial Natriuretic Factor Precursors- Atrial Natriuretic Factor Precursors
- Prepro-Cardiodilatin-Atrial Natriuretic Factor
- Prepro Cardiodilatin Atrial Natriuretic Factor
- Prepro-ANP
- Prepro ANP
- ANF Precursors
- Cardiodilatin Precursor
- Prepro-CDD-ANF
- Prepro CDD ANF
gamma-Atrial Natriuretic Peptide- gamma-Atrial Natriuretic Peptide
- gamma Atrial Natriuretic Peptide
- Atriopeptin Prohormone (1-126)
- Proatrial Natriuretic Factor
- Pronatriodilatin
- Atriopeptin 126
- Cardionatrin IV
- Atrial Natriuretic Factor Prohormone
- Atrial Natriuretic Factor (1-126)
- Atrial Natriuretic Peptide (1-126)
- Atriopeptigen
- ANF (1-126)
- ANP (1-126)
- Atrial Pronatriodilatin
- Pro-ANF
- Pro ANF
- ProANF
|
Below are MeSH descriptors whose meaning is more general than "Atrial Natriuretic Factor".
Below are MeSH descriptors whose meaning is more specific than "Atrial Natriuretic Factor".
This graph shows the total number of publications written about "Atrial Natriuretic Factor" by people in this website by year, and whether "Atrial Natriuretic Factor" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1986 | 1 | 0 | 1 | | 1989 | 2 | 0 | 2 | | 1990 | 1 | 0 | 1 | | 1991 | 5 | 0 | 5 | | 1993 | 1 | 0 | 1 | | 1994 | 0 | 1 | 1 | | 1997 | 3 | 2 | 5 | | 1998 | 0 | 2 | 2 | | 1999 | 0 | 1 | 1 | | 2000 | 1 | 0 | 1 | | 2001 | 0 | 3 | 3 | | 2002 | 0 | 1 | 1 | | 2003 | 0 | 2 | 2 | | 2004 | 0 | 1 | 1 | | 2007 | 0 | 1 | 1 | | 2009 | 1 | 1 | 2 | | 2010 | 2 | 0 | 2 | | 2011 | 0 | 1 | 1 | | 2022 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Atrial Natriuretic Factor" by people in Profiles.
-
Al-Qazazi R, Lima PDA, Prisco SZ, Potus F, Dasgupta A, Chen KH, Tian L, Bentley RET, Mewburn J, Martin AY, Wu D, Jones O, Maurice DH, Bonnet S, Provencher S, Prins KW, Archer SL. Macrophage-NLRP3 Activation Promotes Right Ventricle Failure in Pulmonary Arterial Hypertension. Am J Respir Crit Care Med. 2022 09 01; 206(5):608-624.
-
Tian Y, Mambetsariev I, Sarich N, Meng F, Birukova AA. Role of microtubules in attenuation of PepG-induced vascular endothelial dysfunction by atrial natriuretic peptide. Biochim Biophys Acta. 2015 Jan; 1852(1):104-19.
-
Tian X, Tian Y, Gawlak G, Sarich N, Wu T, Birukova AA. Control of vascular permeability by atrial natriuretic peptide via a GEF-H1-dependent mechanism. J Biol Chem. 2014 Feb 21; 289(8):5168-83.
-
Xing J, Yakubov B, Poroyko V, Birukova AA. Opposite effects of ANP receptors in attenuation of LPS-induced endothelial permeability and lung injury. Microvasc Res. 2012 Mar; 83(2):194-9.
-
Xing J, Moldobaeva N, Birukova AA. Atrial natriuretic peptide protects against Staphylococcus aureus-induced lung injury and endothelial barrier dysfunction. J Appl Physiol (1985). 2011 Jan; 110(1):213-24.
-
Birukova AA, Xing J, Fu P, Yakubov B, Dubrovskyi O, Fortune JA, Klibanov AM, Birukov KG. Atrial natriuretic peptide attenuates LPS-induced lung vascular leak: role of PAK1. Am J Physiol Lung Cell Mol Physiol. 2010 Nov; 299(5):L652-63.
-
Xing J, Birukova AA. ANP attenuates inflammatory signaling and Rho pathway of lung endothelial permeability induced by LPS and TNFalpha. Microvasc Res. 2010 Jan; 79(1):56-62.
-
Chen B, Yates E, Huang Y, Kogut P, Ma L, Turner JR, Tao Y, Camoretti-Mercado B, Lang D, Svensson EC, Garcia JG, Gruber PJ, Morrisey EE, Solway J. Alternative promoter and GATA5 transcripts in mouse. Am J Physiol Gastrointest Liver Physiol. 2009 Dec; 297(6):G1214-22.
-
Birukova AA, Zagranichnaya T, Alekseeva E, Bokoch GM, Birukov KG. Epac/Rap and PKA are novel mechanisms of ANP-induced Rac-mediated pulmonary endothelial barrier protection. J Cell Physiol. 2008 Jun; 215(3):715-24.
-
Suzuki G, Khanal S, Rastogi S, Morita H, Mishima T, Anagnostopoulos PV, Nass O, Sharov VG, Tanhehco EJ, Goldstein S, Sabbah HN. Long-term pharmacological activation of PPARgamma does not prevent left ventricular remodeling in dogs with advanced heart failure. Cardiovasc Drugs Ther. 2007 Feb; 21(1):29-36.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|